JD Supra

Generic ESG Statements Remain Under Fire: Class Certification Granted for the Third Time as the Saga of the Goldman Sachs Securities Litigation Continues

In Goldman Sachs, a class of investors alleged they were misled by Goldman’s written public statements concerning corporate governance issues—i.e., the “G” in ESG, or Environmental, Social and ...
JD Supra

FDA Issues Competitive Generic Therapies (CGTs) Statement and Guidance Regarding CGT Designation, Approval Pathway, and Market Exclusivity

The FDA recently issued a draft guidance (the guidance) outlining various aspects of the Competitive Generics Therapy (CGT) approval pathway, designation, and market exclusivity. 10 The guidance ...